PULMATRIX, INC. Entity Listing, Par Value Per Share
PULMATRIX, INC. (PULM) reported Entity Listing, Par Value Per Share of $0.00 per share for the 12-month period ending 2025-12-31, per its 10-K/A filed 2026-06-16.
Financial Statements › Notes › Cover Page
dei:EntityListingParValuePerShare · last filed 2026-06-16
- PULMATRIX, INC. entity listing, par value per share for fiscal 2025 was $0.00.
| Period end | Entity Listing, Par Value Per Share 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K/A · filed 2026-06-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |